PRIMARY STUDY
Betacaryophyllene – A phytocannabinoid as potential therapeutic modality for human sepsis?
Key Findings: Researchers propose BCP administration as novel treatment to reduce hyper-inflammation in human sepsis.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Canada, Mexico
Year of Pub: 2018
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Receptors Studied: CB2
